Regulatory T Cells in Pathological Cardiac Hypertrophy: Mechanisms and Therapeutic Potential.

Liu, Leiling; Hu, Jiahui; Lei, Hao; Qin, Huali; Wang, Chunfang; Gui, Yajun; Xu, Danyan

Liu, Leiling; Hu, Jiahui; Lei, Hao; Qin, Huali; Wang, Chunfang; Gui, Yajun; Xu, Danyan.

Afiliación

Liu L; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Hu J; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Lei H; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Qin H; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Wang C; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Gui Y; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Xu D; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China. xudanyan02@csu.edu.cn.

Cardiovasc Drugs Ther ; 2023 May 15.

Article en En | MEDLINE | ID: mdl-37184744

Palabras clave

Hypertension; Myocardial infarction; Pathological cardiac hypertrophy; Treg

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cardiovasc Drugs Ther Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google